Feline Hypoglycemia: Causes, Diagnosis, and Management

At a Glance

Feline hypoglycemia is a clinical condition defined by abnormally low blood glucose concentration that requires prompt identification of the underlying cause and appropriate intervention. This article provides veterinary clinicians with a structured approach to diagnosing and managing hypoglycemia in cats, covering etiologies ranging from insulinoma and sepsis to liver disease and neonatal conditions. The table below summarizes the primary causes, key diagnostic features, and initial management considerations.

Pathophysiology of Feline Hypoglycemia

Hypoglycemia in cats results from an imbalance between glucose production and utilization. The body maintains blood glucose through hepatic glycogenolysis and gluconeogenesis, regulated by insulin, glucagon, cortisol, and growth hormone. When glucose demand exceeds supply or when regulatory mechanisms fail, hypoglycemia develops.

The clinical consequences of hypoglycemia stem from inadequate glucose delivery to the brain, which relies on a continuous supply for energy. Neuronal dysfunction occurs when blood glucose falls below approximately 3.3 mmol/L (60 mg/dL), with more severe signs at lower concentrations. The severity of clinical signs depends on the rate of decline, absolute glucose concentration, and individual patient factors.

Causes of Hypoglycemia in Cats

Insulinoma

Insulinoma is a pancreatic beta-cell tumor that secretes insulin autonomously, leading to hypoglycemia. This condition is uncommon in cats but should be considered in middle-aged to older animals presenting with episodic neurologic signs. The tumor may be solitary or multiple, and malignant behavior with metastasis is possible.

Diagnosis requires documentation of hypoglycemia with concurrent hyperinsulinemia. The insulin-to-glucose ratio is a key diagnostic tool. Blood samples should be collected during a hypoglycemic episode for accurate interpretation. Imaging studies, including abdominal ultrasound, may identify a pancreatic mass. One report describes ultrasound-aided diagnosis of an insulinoma in a cat, highlighting the utility of this modality for tumor localization (Ultrasound-aided diagnosis of an insulinoma in a cat, Tierarztliche Praxis Ausgabe K Kleintiere Heimtiere, 2013, https://doi.org/10.1055/s-0038-1623719). Additional biomarkers such as chromogranin A may be elevated in pancreatic islet cell tumors, though this has been studied more extensively in dogs (Chromogranin a plasma concentration and expression in pancreatic islet cell tumors of dogs and cats, American Journal of Veterinary Research, 1997, https://api.elsevier.com/content/abstract/scopus_id/0030738577).

Sepsis

Sepsis causes hypoglycemia through multiple mechanisms, including increased glucose consumption by inflammatory cells and bacteria, impaired hepatic gluconeogenesis, and relative insulin resistance. Feline neonatal sepsis is a particular concern, as kittens have limited glycogen reserves and immature gluconeogenic pathways. One review discusses the pathophysiology and management of feline neonatal sepsis, emphasizing the vulnerability of this age group (Feline neonatal sepsis, The Veterinary clinics of North America. Small animal practice, 1993, https://pubmed.ncbi.nlm.nih.gov/8421891).

In adult cats, sepsis-related hypoglycemia is often a poor prognostic indicator. The presence of hypoglycemia in a septic patient should prompt aggressive treatment of the underlying infection and supportive care.

Liver Disease

The liver plays a central role in glucose homeostasis through glycogen storage and gluconeogenesis. Hepatic lipidosis, portosystemic shunts, and other liver diseases can impair these functions, leading to hypoglycemia. Cats with hepatic lipidosis often present with anorexia, weight loss, and icterus. Hypoglycemia may develop as the disease progresses, particularly if the cat is not eating.

Portosystemic shunts allow blood to bypass the liver, reducing hepatic clearance of insulin and other substances. This can result in hypoglycemia, especially after meals. Diagnosis requires bile acid testing and imaging studies such as ultrasound or scintigraphy.

Neonatal Hypoglycemia

Kittens are at high risk for hypoglycemia due to their high metabolic rate, limited glycogen stores, and immature gluconeogenic capacity. Hypoglycemia is common in kittens that are not nursing adequately, are hypothermic, or have underlying illness. Clinical signs include lethargy, weakness, hypothermia, and seizures.

Management involves warming the kitten, providing a glucose source, and addressing the underlying cause. Fluid therapy for pediatric patients requires careful attention to glucose and electrolyte balance (Fluid Therapy for Pediatric Patients, The Veterinary clinics of North America. Small animal practice, 2017, https://pubmed.ncbi.nlm.nih.gov/27939859).

Other Causes

Other causes of hypoglycemia in cats include:

• Insulin overdose: Iatrogenic hypoglycemia is a common complication of insulin therapy in diabetic cats. The iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats provide recommendations for insulin dosing and monitoring to minimize this risk (iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats, Journal of feline medicine and surgery, 2025, https://pubmed.ncbi.nlm.nih.gov/41224734).
• Hypoadrenocorticism: Cortisol deficiency impairs gluconeogenesis and glycogenolysis.
• Severe malnutrition or starvation: Prolonged anorexia depletes glycogen stores.
• Paraneoplastic syndromes: Some tumors produce insulin-like growth factors.
• Glycogen storage diseases: Rare inherited disorders of glycogen metabolism.

Diagnostic Approach

History and Physical Examination

A thorough history should include information about the cat's age, diet, medications (especially insulin), and any previous episodes of weakness or collapse. Owners may report lethargy, ataxia, disorientation, or seizures. The physical examination should assess mentation, body condition, hydration status, and evidence of underlying disease such as hepatomegaly, icterus, or fever.

Blood Glucose Measurement

Blood glucose should be measured using a validated glucometer or laboratory analyzer. Samples should be collected from a peripheral vein, and the measurement should be performed promptly to avoid glycolysis. A blood glucose concentration below 3.3 mmol/L (60 mg/dL) is generally considered hypoglycemic, though clinical signs may not be present until levels fall below 2.8 mmol/L (50 mg/dL).

Diagnostic Testing

The diagnostic workup should be guided by the suspected cause. Recommended tests include:

• Complete blood count and serum biochemistry: Evaluate for evidence of infection, liver disease, or other organ dysfunction.
• Insulin concentration: Measured during a hypoglycemic episode. A normal or elevated insulin level in the face of hypoglycemia suggests insulinoma or exogenous insulin administration.
• Insulin-to-glucose ratio: Calculated as insulin (μU/mL) divided by glucose (mg/dL). A ratio above 30 is suggestive of insulinoma, though this threshold is not absolute.
• Bile acids: Pre- and post-prandial bile acid testing to evaluate liver function and portosystemic shunting.
• Cortisol testing: ACTH stimulation test to diagnose hypoadrenocorticism.
• Imaging: Abdominal ultrasound to identify pancreatic masses, liver disease, or portosystemic shunts.
• Urinalysis and culture: To identify urinary tract infection as a source of sepsis.

Insulinoma Diagnosis

Diagnosis of insulinoma requires documentation of hypoglycemia with concurrent hyperinsulinemia. The insulin-to-glucose ratio is a useful screening tool, but false positives can occur. Imaging studies are essential for tumor localization. Abdominal ultrasound may identify a pancreatic mass, though small tumors may be difficult to visualize. Advanced imaging such as computed tomography or magnetic resonance imaging may be necessary.

Emergency Management

Initial Stabilization

The immediate goal in a hypoglycemic cat is to raise blood glucose to a safe level. For conscious cats with mild signs, oral administration of a glucose solution or corn syrup can be effective. For unconscious or seizing cats, intravenous dextrose is required.

A 50% dextrose solution should be diluted to 25% or 12.5% for intravenous administration. The dose is typically 0.5 to 1 mL/kg of 50% dextrose, given slowly over 5 to 10 minutes. Blood glucose should be rechecked after administration to ensure an adequate response.

Ongoing Support

After initial stabilization, a continuous rate infusion of dextrose may be necessary to maintain euglycemia. The infusion rate should be adjusted based on serial blood glucose measurements. For cats with insulinoma, dextrose alone may not be sufficient, and additional therapies such as glucagon may be considered. Glucagon has been used in the management of hypoglycemia, though its use in cats is less well documented (Glucagon, La Presse medicale, 1969, https://pubmed.ncbi.nlm.nih.gov/5262975).

Monitoring

Blood glucose should be monitored frequently during the acute phase, with measurements every 1 to 2 hours until stable. Once the cat is eating and blood glucose is stable, monitoring can be reduced to every 4 to 6 hours. Owners should be educated to recognize signs of hypoglycemia and to have a glucose source available at home.

Long-Term Management

Insulinoma

Surgical resection is the treatment of choice for insulinoma. Preoperative localization of the tumor is important for surgical planning. If the tumor cannot be localized, exploratory laparotomy with pancreatic inspection and biopsy may be necessary. Medical management with diazoxide or glucocorticoids may be used if surgery is not possible or if metastasis is present.

Sepsis

Treatment of sepsis-related hypoglycemia focuses on controlling the underlying infection. Antibiotic therapy should be based on culture and sensitivity results. Supportive care includes intravenous fluids, nutritional support, and glucose supplementation as needed.

Liver Disease

Management of hepatic lipidosis requires aggressive nutritional support, often through a feeding tube. Hypoglycemia should be addressed with dextrose supplementation until the cat is eating adequately. Portosystemic shunts may be managed medically with lactulose and antibiotics, or surgically with shunt attenuation.

Neonatal Hypoglycemia

Kittens with hypoglycemia should be warmed gradually and provided with a glucose source. Oral glucose solutions or commercial kitten milk replacers can be used. If the kitten is unable to nurse, parenteral dextrose may be necessary. The underlying cause, such as poor nursing or infection, must be addressed.

Insulin Overdose

For diabetic cats with iatrogenic hypoglycemia, the insulin dose should be reduced. The iCatCare 2025 consensus guidelines provide recommendations for adjusting insulin therapy based on blood glucose curves (iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats, Journal of feline medicine and surgery, 2025, https://pubmed.ncbi.nlm.nih.gov/41224734). Owners should be instructed to monitor for signs of hypoglycemia and to have a glucose source available.

Practical Implementation Steps

Step 1: Confirm Hypoglycemia

Measure blood glucose using a validated glucometer or laboratory analyzer. Repeat the measurement if the result is unexpectedly low. Document the time of measurement and the cat's clinical status.

Step 2: Assess Clinical Signs

Evaluate the cat for signs of hypoglycemia, including lethargy, weakness, ataxia, disorientation, seizures, or coma. The presence of clinical signs guides the urgency of intervention.

Step 3: Provide Emergency Glucose

For cats with clinical signs, administer dextrose as described above. For cats without clinical signs, provide a glucose source orally if the cat is able to eat.

Step 4: Identify Underlying Cause

Perform a thorough history and physical examination. Order diagnostic tests based on the suspected cause. Consider insulinoma, sepsis, liver disease, neonatal hypoglycemia, and other causes.

Step 5: Initiate Specific Treatment

Treat the underlying cause. For insulinoma, surgical referral is indicated. For sepsis, antibiotics and supportive care. For liver disease, nutritional support and medical management. For neonatal hypoglycemia, warming and glucose supplementation.

Step 6: Monitor and Adjust

Monitor blood glucose frequently during the acute phase. Adjust dextrose infusion rates as needed. Once stable, transition to oral feeding and reduce monitoring frequency.

Step 7: Educate Owner

Provide the owner with information about hypoglycemia, including signs to watch for and how to respond. For diabetic cats, review insulin administration and monitoring techniques.

Records and Measurements

Blood Glucose Log

Maintain a log of blood glucose measurements, including date, time, value, and clinical signs. This log is essential for identifying patterns and adjusting treatment.

Insulin Administration Record

For diabetic cats, record the type, dose, and time of each insulin injection. Note any changes in appetite, activity, or clinical signs.

Diagnostic Test Results

Document all diagnostic test results, including complete blood count, serum biochemistry, insulin concentration, and imaging findings. These results guide diagnosis and treatment decisions.

Treatment Response

Record the cat's response to treatment, including changes in blood glucose, clinical signs, and appetite. This information is used to adjust therapy.

Common Failure Patterns

Failure to Identify Underlying Cause

Hypoglycemia is a sign, not a diagnosis. Treating the hypoglycemia without identifying the underlying cause leads to recurrent episodes and progression of the primary disease.

Inadequate Monitoring

Infrequent blood glucose monitoring can result in missed hypoglycemic episodes. For cats on insulin therapy, regular blood glucose curves are essential.

Overcorrection with Dextrose

Administering too much dextrose can cause hyperglycemia, which may lead to osmotic diuresis and electrolyte disturbances. Dextrose should be given slowly and titrated to effect.

Delayed Surgical Referral

For cats with insulinoma, delayed surgical referral can allow tumor progression and metastasis. Early localization and surgical intervention improve outcomes.

Inadequate Nutritional Support

Cats with liver disease or neonatal hypoglycemia require aggressive nutritional support. Failure to provide adequate calories can perpetuate hypoglycemia.

Limitations and Professional Escalation Criteria

Limitations

• The diagnosis of insulinoma can be challenging, as small tumors may not be visible on ultrasound.
• The insulin-to-glucose ratio is a screening tool and is not diagnostic.
• Medical management of insulinoma is palliative and does not address the underlying tumor.
• Neonatal kittens are fragile and require careful monitoring and supportive care.

Escalation Criteria

• Urgent veterinary consultation: Any cat with hypoglycemia and clinical signs such as seizures, coma, or severe weakness requires immediate veterinary attention.
• Referral to internal medicine specialist: Cats with suspected insulinoma, complex liver disease, or recurrent hypoglycemia of unknown cause should be referred to a veterinary internal medicine specialist.
• Surgical referral: Cats with confirmed or suspected insulinoma should be referred for surgical evaluation.
• Critical care referral: Cats with severe sepsis, hepatic encephalopathy, or other life-threatening conditions may require intensive care unit management.

Welfare and Safety Context

Hypoglycemia is a painful and distressing condition for cats. Prompt recognition and treatment are essential for animal welfare. The World Organisation for Animal Health provides guidelines for animal health and welfare, emphasizing the importance of timely veterinary care (Animal Health and Welfare, World Organisation for Animal Health, https://www.woah.org/en/what-we-do/animal-health-and-welfare).

For diabetic cats, careful insulin management and monitoring are critical to prevent iatrogenic hypoglycemia. The iCatCare 2025 consensus guidelines provide evidence-based recommendations for diabetes management (iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats, Journal of feline medicine and surgery, 2025, https://pubmed.ncbi.nlm.nih.gov/41224734).

Practical Decision Framework for Differentiating Hypoglycemia Etiologies in Cats

A structured decision framework helps clinicians move from the initial finding of low blood glucose to a specific diagnosis and targeted treatment plan. The following framework integrates history, physical examination findings, and sequential diagnostic testing to differentiate the most common causes of feline hypoglycemia. This approach reduces the risk of treating the sign without identifying the underlying disease, a common failure pattern in hypoglycemia management.

Stepwise Clinical Decision Algorithm

Step 1: Classify the Patient by Age and Risk Profile

The first branch point in the decision framework is patient age and clinical context. Neonatal kittens under four weeks of age represent a distinct category with unique pathophysiology and management requirements. For kittens, the primary considerations are inadequate nursing, hypothermia, and sepsis. The Merck Veterinary Manual notes that neonatal hypoglycemia is a common presenting complaint in kittens and requires immediate intervention (Merck Veterinary Manual, https://www.merckvetmanual.com/). For adult cats, the differential diagnosis expands to include insulinoma, sepsis, liver disease, and iatrogenic causes.

Step 2: Assess for Iatrogenic Causes

In any cat receiving insulin therapy, iatrogenic hypoglycemia must be the first consideration. The iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats emphasize that insulin overdose is a preventable cause of hypoglycemia that requires dose adjustment and owner education (iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats, Journal of feline medicine and surgery, 2025, https://pubmed.ncbi.nlm.nih.gov/41224734). Ask the owner about the type and dose of insulin, the timing of the last injection, and whether the cat has eaten normally. If the cat missed a meal after receiving insulin, hypoglycemia is likely. Review the insulin administration record if available.

Step 3: Evaluate for Sepsis

Sepsis should be suspected in cats with fever or hypothermia, lethargy, and evidence of an infectious focus. Common sources include urinary tract infections, pneumonia, dental disease, and wounds. Feline neonatal sepsis is a particular concern in kittens and carries a high mortality rate if not recognized promptly (Feline neonatal sepsis, The Veterinary clinics of North America. Small animal practice, 1993, https://pubmed.ncbi.nlm.nih.gov/8421891). Perform a complete blood count to evaluate for leukocytosis or leukopenia with a left shift. Obtain urine for urinalysis and culture. If sepsis is confirmed, treatment of the underlying infection is the priority, with glucose support as needed.

Step 4: Assess Liver Function

Liver disease should be considered in cats with icterus, hepatomegaly, or a history of anorexia and weight loss. Hepatic lipidosis is a common cause of liver dysfunction in cats and can lead to hypoglycemia as the disease progresses. Portosystemic shunts may cause hypoglycemia, particularly after meals, and should be suspected in young cats with neurologic signs. Pre- and post-prandial bile acid testing is the initial screening test for liver function and portosystemic shunting. The American College of Veterinary Internal Medicine provides resources on the diagnosis and management of liver disease in small animals (ACVIM, https://www.acvim.org/).

Step 5: Consider Insulinoma

Insulinoma should be suspected in middle-aged to older cats with episodic neurologic signs and documented hypoglycemia. The diagnosis requires demonstration of hypoglycemia with concurrent hyperinsulinemia. The insulin-to-glucose ratio is a useful screening tool, but false positives can occur, particularly in cats with sepsis or liver disease. Abdominal ultrasound is the initial imaging modality for tumor localization. One report describes ultrasound-aided diagnosis of an insulinoma in a cat, highlighting the utility of this modality (Ultrasound-aided diagnosis of an insulinoma in a cat, Tierarztliche Praxis Ausgabe K Kleintiere Heimtiere, 2013, https://doi.org/10.1055/s-0038-1623719). If ultrasound is inconclusive, advanced imaging such as computed tomography may be necessary.

Step 6: Evaluate for Hypoadrenocorticism

Hypoadrenocorticism is an uncommon cause of hypoglycemia in cats but should be considered when other causes have been excluded. Clinical signs include lethargy, weakness, and gastrointestinal signs. An ACTH stimulation test is required for diagnosis. Cortisol deficiency impairs gluconeogenesis and glycogenolysis, leading to hypoglycemia.

Decision Matrix for Common Clinical Scenarios

The following decision matrix provides a rapid reference for clinicians based on the presenting clinical scenario.

Troubleshooting Method for Recurrent or Refractory Hypoglycemia

When hypoglycemia persists despite initial treatment or recurs after stabilization, a systematic troubleshooting approach is necessary. The following method addresses common reasons for treatment failure.

Step 1: Verify Blood Glucose Measurement

Ensure that the glucometer or laboratory analyzer is functioning correctly and that the sample was handled appropriately. Glycolysis can occur if the sample is not processed promptly, leading to falsely low readings. Repeat the measurement on a fresh sample if there is any doubt about the accuracy of the initial result.

Step 2: Assess Dextrose Administration

Review the dose and rate of dextrose administration. Inadequate dosing is a common cause of persistent hypoglycemia. The initial bolus of 0.5 to 1 mL/kg of 50% dextrose (diluted to 25% or 12.5%) should be followed by a continuous rate infusion if needed. The infusion rate should be adjusted based on serial blood glucose measurements. Overcorrection with dextrose can cause hyperglycemia, which may lead to osmotic diuresis and electrolyte disturbances.

Step 3: Re-evaluate the Underlying Cause

If hypoglycemia persists despite adequate dextrose support, the underlying cause may be more severe than initially suspected. Consider the following possibilities:

• Insulinoma: The tumor may be secreting large amounts of insulin that overwhelm the dextrose infusion. Glucagon therapy may be necessary. Glucagon has been used in the management of hypoglycemia, though its use in cats is less well documented (Glucagon, La Presse medicale, 1969, https://pubmed.ncbi.nlm.nih.gov/5262975).
• Severe sepsis: The metabolic demands of sepsis may be higher than anticipated. Aggressive treatment of the underlying infection is essential.
• Advanced liver disease: Hepatic gluconeogenesis may be severely impaired. Nutritional support and dextrose supplementation may need to be intensified.
• Hypoadrenocorticism: Cortisol deficiency may be contributing to refractory hypoglycemia. An ACTH stimulation test should be performed if not already done.

Step 4: Evaluate for Concurrent Conditions

Cats with hypoglycemia may have multiple concurrent conditions that complicate management. For example, a diabetic cat with sepsis may have both iatrogenic and sepsis-related hypoglycemia. A cat with hepatic lipidosis may also have pancreatitis or inflammatory bowel disease. A thorough diagnostic workup is essential to identify all contributing factors.

Step 5: Consider Referral

If hypoglycemia remains refractory after addressing the above factors, referral to a veterinary internal medicine specialist or critical care facility is indicated. The ACVIM provides a directory of board-certified specialists (ACVIM, https://www.acvim.org/). Cats with suspected insulinoma that cannot be localized on ultrasound may benefit from advanced imaging or exploratory laparotomy.

Record System for Hypoglycemia Management

A standardized record system improves the quality of care and facilitates communication among the veterinary team. The following records should be maintained for any cat with hypoglycemia.

Blood Glucose Monitoring Log

Maintain a log of all blood glucose measurements, including the date, time, value, and the cat's clinical status at the time of measurement. This log is essential for identifying trends and adjusting treatment. Record the method of measurement (e.g., glucometer, laboratory analyzer) and any factors that may affect the result, such as recent feeding or dextrose administration.

Treatment Administration Record

Document all treatments administered, including the type, dose, route, and time of administration. For dextrose, record the concentration, volume, and rate of infusion. For insulin, record the type, dose, and time of injection. Note any adverse reactions or complications.

Diagnostic Test Results

Maintain a file of all diagnostic test results, including complete blood count, serum biochemistry, insulin concentration, insulin-to-glucose ratio, bile acids, cortisol levels, and imaging findings. These results are essential for diagnosis and treatment decisions.

Owner Communication Log

Document all communications with the owner, including instructions for home monitoring, signs of hypoglycemia to watch for, and emergency contact information. For diabetic cats, review insulin administration and monitoring techniques. The iCatCare 2025 consensus guidelines provide recommendations for owner education (iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats, Journal of feline medicine and surgery, 2025, https://pubmed.ncbi.nlm.nih.gov/41224734).

Common Failure Patterns in the Decision Framework

Failure to Consider Age-Appropriate Differentials

A common mistake is applying the same differential diagnosis to all cats regardless of age. Neonatal kittens require a different diagnostic approach than adult cats. The Merck Veterinary Manual provides age-specific guidance for the evaluation of hypoglycemia (Merck Veterinary Manual, https://www.merckvetmanual.com/).

Overreliance on the Insulin-to-Glucose Ratio

The insulin-to-glucose ratio is a screening tool, not a diagnostic test. False positives can occur in cats with sepsis, liver disease, or other conditions that cause hypoglycemia. A normal or elevated insulin level in the face of hypoglycemia is suggestive of insulinoma, but the diagnosis should be confirmed with imaging and, if necessary, surgical biopsy.

Delayed Surgical Referral for Insulinoma

For cats with suspected insulinoma, early surgical referral is essential. Delayed referral can allow tumor progression and metastasis. The decision to refer should be made as soon as the diagnosis is suspected, not after medical management has failed.

Inadequate Nutritional Support

Cats with liver disease or neonatal hypoglycemia require aggressive nutritional support. Failure to provide adequate calories can perpetuate hypoglycemia and delay recovery. For cats with hepatic lipidosis, a feeding tube is often necessary to ensure adequate caloric intake.

Professional Escalation Criteria

The following criteria indicate the need for escalation of care to a specialist or referral facility.

Urgent Veterinary Consultation

Any cat with hypoglycemia and clinical signs such as seizures, coma, or severe weakness requires immediate veterinary attention. If the cat is not already hospitalized, the owner should be instructed to bring the cat to the nearest veterinary emergency facility.

Referral to Internal Medicine Specialist

Cats with suspected insulinoma, complex liver disease, or recurrent hypoglycemia of unknown cause should be referred to a veterinary internal medicine specialist. The ACVIM provides a directory of board-certified specialists (ACVIM, https://www.acvim.org/).

Surgical Referral

Cats with confirmed or suspected insulinoma should be referred for surgical evaluation. Preoperative localization of the tumor is important for surgical planning. If the tumor cannot be localized, exploratory laparotomy with pancreatic inspection and biopsy may be necessary.

Critical Care Referral

Cats with severe sepsis, hepatic encephalopathy, or other life-threatening conditions may require intensive care unit management. Facilities with 24-hour monitoring and advanced supportive care capabilities are preferred.

Welfare and Safety Context

Hypoglycemia is a painful and distressing condition for cats. Prompt recognition and treatment are essential for animal welfare. The World Organisation for Animal Health provides guidelines for animal health and welfare, emphasizing the importance of timely veterinary care (Animal Health and Welfare, World Organisation for Animal Health, https://www.woah.org/en/what-we-do/animal-health-and-welfare). For diabetic cats, careful insulin management and monitoring are critical to prevent iatrogenic hypoglycemia. The iCatCare 2025 consensus guidelines provide evidence-based recommendations for diabetes management (iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats, Journal of feline medicine and surgery, 2025, https://pubmed.ncbi.nlm.nih.gov/41224734).

The Cat Veterinary Society provides guidelines for the management of feline patients, including those with endocrine disorders (CatVets, https://catvets.com/guidelines). These guidelines emphasize the importance of a thorough diagnostic workup and individualized treatment plans.

Limitations of the Decision Framework

The decision framework presented here is a guide and should not replace clinical judgment. Some cats may present with atypical signs or have multiple concurrent conditions that complicate the diagnostic process. The insulin-to-glucose ratio is a screening tool and is not diagnostic. Small insulinomas may not be visible on ultrasound, and advanced imaging may be necessary. Medical management of insulinoma is palliative and does not address the underlying tumor. Neonatal kittens are fragile and require careful monitoring and supportive care. Fluid therapy for pediatric patients requires careful attention to glucose and electrolyte balance (Fluid Therapy for Pediatric Patients, The Veterinary clinics of North America. Small animal practice, 2017, https://pubmed.ncbi.nlm.nih.gov/27939859).

Summary of the Decision Framework

The practical decision framework for differentiating hypoglycemia etiologies in cats begins with patient classification by age and risk profile, followed by sequential evaluation for iatrogenic causes, sepsis, liver disease, insulinoma, and hypoadrenocorticism. A decision matrix provides rapid reference for common clinical scenarios. The troubleshooting method addresses recurrent or refractory hypoglycemia through verification of blood glucose measurement, assessment of dextrose administration, re-evaluation of the underlying cause, evaluation for concurrent conditions, and consideration of referral. A standardized record system improves the quality of care and facilitates communication. Common failure patterns include failure to consider age-appropriate differentials, overreliance on the insulin-to-glucose ratio, delayed surgical referral for insulinoma, and inadequate nutritional support. Professional escalation criteria guide the clinician in determining when referral to a specialist or critical care facility is indicated. This framework reduces the risk of treating the sign without identifying the underlying disease and improves outcomes for cats with hypoglycemia.

Frequently Asked Questions

What is the most common cause of hypoglycemia in cats?

The most common cause depends on the patient population. In diabetic cats, insulin overdose is the most frequent cause. In kittens, neonatal hypoglycemia is common. In adult cats without diabetes, insulinoma, sepsis, and liver disease are important considerations.

How is feline insulinoma diagnosed?

Diagnosis requires documentation of hypoglycemia with concurrent hyperinsulinemia. The insulin-to-glucose ratio is a screening tool. Imaging studies, particularly abdominal ultrasound, are used for tumor localization. Diagnosis may require surgical biopsy.

Can hypoglycemia in cats be treated at home?

Mild hypoglycemia in a conscious cat can be treated at home with oral glucose or corn syrup. However, any cat with clinical signs such as seizures, coma, or severe weakness requires immediate veterinary attention. The underlying cause must be identified and treated.

What is the prognosis for a cat with insulinoma?

The prognosis depends on tumor stage and surgical resectability. Cats with solitary, resectable tumors have a better prognosis. Metastatic disease carries a guarded prognosis. Medical management can provide palliation but is not curative.

How is neonatal hypoglycemia managed in kittens?

Kittens should be warmed gradually and provided with a glucose source. Oral glucose solutions or commercial kitten milk replacers can be used. If the kitten is unable to nurse, parenteral dextrose may be necessary. The underlying cause, such as poor nursing or infection, must be addressed.

What are the signs of hypoglycemia in cats?

Signs include lethargy, weakness, ataxia, disorientation, seizures, and coma. Some cats may show behavioral changes such as aggression or hiding. The severity of signs depends on the degree and rate of blood glucose decline.

How often should blood glucose be monitored in a hypoglycemic cat?

During the acute phase, blood glucose should be monitored every 1 to 2 hours until stable. Once the cat is eating and blood glucose is stable, monitoring can be reduced to every 4 to 6 hours. For diabetic cats, regular blood glucose curves are recommended.

Can liver disease cause hypoglycemia in cats?

Yes, liver disease can cause hypoglycemia through impaired gluconeogenesis and glycogenolysis. Hepatic lipidosis and portosystemic shunts are common causes. Management requires addressing the underlying liver condition and providing nutritional support.

Related Veterinary Guides

• Cat
• Chronic Kidney Disease In Cats
• Symptoms Of Kidney Disease In My Cat
• Symptoms Of Kidney Disease In Old Cats
• Symptoms Of Kidney Disease In Senior Cats

References and Further Reading

• www.merckvetmanual.com
• catvets.com
• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats.. Journal of feline medicine and surgery, 2025.
• [Therapy of canine parvovirus infection - review and current insights].. Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere, 2020.
• Feline neonatal sepsis.. The Veterinary clinics of North America. Small animal practice, 1993.
• Managing feline diabetes: current perspectives.. Veterinary medicine (Auckland, N.Z.), 2018.
• Fluid Therapy for Pediatric Patients.. The Veterinary clinics of North America. Small animal practice, 2017.
• [Glucagon].. La Presse medicale, 1969.
• Ultrasound-aided diagnosis of an insulinoma in a cat. Tierarztliche Praxis Ausgabe K Kleintiere Heimtiere, 2013.
• Chromogranin a plasma concentration and expression in pancreatic islet cell tumors of dogs and cats. American Journal of Veterinary Research, 1997.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.